A Randomised Cross-over Study With Two 1-piece Urostomy Bags.
DK188OS
A Comparative, Randomised, Crossover Study With 2 Urostomy Bags Among 30 Urostomy-operated Persons in UK
1 other identifier
interventional
27
1 country
6
Brief Summary
Background Urostomy is a surgical procedure that detours or diverts urine away form a diseased or defective bladder. The bladder can be removed and the urine is passed out of the body through an opening (stoma) in the stomach. People with urostomy will not be able to start and stop urine coming out through the stoma, so a urostomy bag will be fitted to collect the urine as it comes out. A urostomy bag consists of an adhesive, which is attached to the skin around the stoma and a bag connected to the adhesive to collect the urine. It is very important the standard is high on these products; otherwise the user (urostomy-patient) will experience lots of problems with the skin around the stoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Oct 2008
Shorter than P25 for phase_4
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2008
CompletedStudy Start
First participant enrolled
October 1, 2008
CompletedFirst Posted
Study publicly available on registry
October 2, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2009
CompletedResults Posted
Study results publicly available
March 11, 2014
CompletedMarch 11, 2014
August 1, 2012
7 months
October 1, 2008
September 19, 2011
January 27, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Preference of Sensura vs Moderma
Subjects were asked which of the tested products they preferred; SenSura or Moderma.
4 weeks
Secondary Outcomes (11)
Immediate Adhesion
4 weeks
Removal of the Bag
4 weeks
Adhesion of the Bag During Use
4 weeks
Adhesives Ability to Absorb Perspiration
4 weeks
Flexibility of the Product
4 weeks
- +6 more secondary outcomes
Study Arms (2)
SenSura Uro
EXPERIMENTALThe test product is a CE-marked non-sterile one-piece urostomy multi-chamber bag with the SenSura adhesive.
hollister Uro
ACTIVE COMPARATORThe comparator product is CE-marked and non-sterile and produced for urostomy operated. It is a flat one-piece urostomy product, Hollister Moderma Flex Urostomy beige, Cut-to-Fit Bag, flat adhesive
Interventions
The test product is a CE-marked non-sterile one-piece urostomy multi-chamber bag with the SenSura adhesive.
The comparator product is CE-marked and non-sterile and produced for urostomy operated. It is a flat one-piece urostomy product, Hollister Moderma Flex Urostomy beige, Cut-to-Fit Bag, flat adhesive.
Eligibility Criteria
You may qualify if:
- In order to be enrolled in the clinical investigation, the subject must:
- Be at least 18 years old,
- Be mentally and physically capable of signing the written consent form
- Be able to fill in the Case Report Form (questionnaire)
- Have an urostomy with a size between 15-55 mm.
- Have had the urostomy for 3 months or more,
- Use a 1-piece bag normally.
- Be able to handle the bag themselves (application and removal)
- Be willing to use Coloplast SenSura 1-piece bag
- Be willing to use Hollisters Moderma Flex, 1-piece bag
You may not qualify if:
- In order to be enrolled in the clinical investigation, the subjects must not:
- Be a convex base plate user (i.e. a bowl-shaped adhesive which pushes the stoma forward)
- Need to use an ostomy belt
- Be currently suffering from any dermatologiacal problems, needing special treatment, in the peristomal area (investigator will evaluate skin according to a newly developed ostomy skin tool from Coloplast A/S)
- Being treated with chemo- or radiation therapy,
- Be hospitalized during study enrollment, or have a hospitalization or significant surgery planned during the 4-week study period, or
- Be pregnant or breast-feeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Coloplast A/Slead
Study Sites (6)
St. Peters Hospital
Chertsey, Surrey, KT16OPZ, United Kingdom
Caroline Rudoni
London, Tooting, SW17OQT, United Kingdom
Maureen Bridgland
Brighton, United Kingdom
Michael Lynch
Colchester, CO45JL, United Kingdom
University of London Hospital
London, WC1E 5DB, United Kingdom
Theresa Bowles
Norwich, United Kingdom
Results Point of Contact
- Title
- Seema Suchdev Wrisberg
- Organization
- Coloplast A/S
Study Officials
- STUDY CHAIR
Carol Katte, Stoma Nurse
Ashford and St. Peters Hospital
- PRINCIPAL INVESTIGATOR
Maureen Bridgland, Stoma Nurse
Royal Sussex County Hospital
- PRINCIPAL INVESTIGATOR
Caroline Rudoni, Stoma Nurse
St. Georges Hospital
- PRINCIPAL INVESTIGATOR
Theresa Bowles, Stoma Nurse
Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
- PRINCIPAL INVESTIGATOR
Michael Lynch, Surgeon
Colchester General Hospital
- PRINCIPAL INVESTIGATOR
Sharon Fillingham, Nurse
UCLH
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2008
First Posted
October 2, 2008
Study Start
October 1, 2008
Primary Completion
May 1, 2009
Study Completion
May 1, 2009
Last Updated
March 11, 2014
Results First Posted
March 11, 2014
Record last verified: 2012-08